FDA Inspection 1249419 — Qidong Dongyue Pharmaceutical Co. Ltd.
The FDA completed an inspection of Qidong Dongyue Pharmaceutical Co. Ltd. on Aug 16, 2024 in Qidong. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Qidong (China)